Stay updated with breaking news from Brickell Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Management with embattled drug maker Fresh Tracks Therapeutics Inc. (Nasdaq: FRTX), who have spent weeks trying to drum up support for a plan that would see the company dissolved and liquidated, now say they don’t think they have enough shareholder backing for that plan.
Embattled drug maker Fresh Tracks Therapeutics Inc. (Nasdaq: FRTX) will no longer have its stock traded on the Nasdaq exchange as of Tuesday and will immediately begin trading on the over-the-counter market.
Brickell Biotech, Inc. (NASDAQ:BBI – Get Free Report)’s stock price traded up 2.1% during trading on Monday . The company traded as high as $0.80 and last traded at $0.79. 8,874 shares traded hands during trading, a decline of 96% from the average session volume of 206,730 shares. The stock had previously closed at $0.77. […]
Fresh Tracks Therapeutics Inc. shareholders are set to vote this month to dissolve the company, a move that the drug developer expects to result in $5M-$7M returned to shareholders.
BOULDER — It’s been a wild ride over the past year or so for Fresh Tracks Therapeutics Inc., which plans to dissolve, liquidate and eliminate its workforce after failing to find a buyer or merger partner.